These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29952476)

  • 1. Peripheral artery disease: endovascular therapy.
    Lichtenberg M
    Med Monatsschr Pharm; 2017 Mar; 40(3):102-6. PubMed ID: 29952476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endovascular approach for in-stent restenosis in femoropopliteal disease.
    Cannavale A; Tsetis D; Krokidis M
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):391-401. PubMed ID: 25761905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Eluting Stent Implantation and Long-Term Survival Following Peripheral Artery Revascularization.
    Secemsky EA; Kundi H; Weinberg I; Schermerhorn M; Beckman JA; Parikh SA; Jaff MR; Mustapha J; Rosenfield K; Yeh RW
    J Am Coll Cardiol; 2019 May; 73(20):2636-2638. PubMed ID: 30831175
    [No Abstract]   [Full Text] [Related]  

  • 4. New Innovations in Drug-Eluting Stents for Peripheral Arterial Disease.
    Altit R; Gray WA
    Curr Cardiol Rep; 2017 Oct; 19(11):117. PubMed ID: 29027096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-Coated Balloons and Stents for Lower Extremity Peripheral Arterial Disease Interventions: A Regulatory Perspective for the Practicing Clinician.
    Vallabhajosyula S; Greenberg-Worisek AJ; Gulati R; Vallabhajosyula S; Windebank AJ; Misra S; Barsness GW
    Mayo Clin Proc; 2020 Aug; 95(8):1569-1573. PubMed ID: 32753129
    [No Abstract]   [Full Text] [Related]  

  • 6. Endovascular intervention for peripheral artery disease.
    Thukkani AK; Kinlay S
    Circ Res; 2015 Apr; 116(9):1599-613. PubMed ID: 25908731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis after endovascular revascularization in peripheral artery disease.
    Malyar NM; Reinecke H; Freisinger E
    Vasa; 2015 Jul; 44(4):257-70. PubMed ID: 26314357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.
    Armstrong EJ; Bishu K; Waldo SW
    Curr Cardiol Rep; 2016 Apr; 18(4):34. PubMed ID: 26915012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular stents: a review of their use in peripheral arterial disease.
    Kudagi VS; White CJ
    Am J Cardiovasc Drugs; 2013 Jun; 13(3):199-212. PubMed ID: 23579965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
    Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S
    JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Vascular Restenosis: A Retrospective Study on the Use of Drug-Eluting Balloons in Native Arteries, Vein Grafts and Dialysis Accesses.
    Björkman P; Peltola E; Albäck A; Venermo M
    Scand J Surg; 2017 Jun; 106(2):158-164. PubMed ID: 27270469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For which peripheral lesions could we consider drug eluting stents?
    Tessarek J
    J Cardiovasc Surg (Torino); 2016 Apr; 57(2):257-65. PubMed ID: 26675837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radial access for endovascular ilio-femoral procedures.
    Touma J; Coscas R; Ijaverliat I; Lamas H; Coggia M; Goëau-Brissonniere O
    J Cardiovasc Surg (Torino); 2016 Apr; 57(2):302-10. PubMed ID: 26675836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular Intervention in the Treatment of Peripheral Artery Disease.
    Couto M; Figueróa A; Sotolongo A; Pérez R; Ojeda JM
    Bol Asoc Med P R; 2015; 107(3):47-51. PubMed ID: 26742196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup.
    Bosiers M; Peeters P; Tessarek J; Deloose K; Strickler S;
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1):115-22. PubMed ID: 23296421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbated Peri-Stent Contrast Staining on Serial Angiography and Optical Coherence Tomography After Platinum-Chromium Everolimus-Eluting Stent Implantation for Infrapopliteal Artery Lesions.
    Tomoi Y; Kuramitsu S; Soga Y; Hiramori S; Ando K
    Int Heart J; 2018 Jul; 59(4):895-898. PubMed ID: 29794389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Artery Disease: Evolving Role of Exercise, Medical Therapy, and Endovascular Options.
    Olin JW; White CJ; Armstrong EJ; Kadian-Dodov D; Hiatt WR
    J Am Coll Cardiol; 2016 Mar; 67(11):1338-57. PubMed ID: 26988957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endovascular therapy in the treatment of critical limb ischemia.
    Menard M
    Angiol Sosud Khir; 2014; 20(1):53-5, 57-9. PubMed ID: 24722021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating with an implant: BMS or DES?
    Marques L; Preiss M; Preuss H; Hopf-Jensen S; Mueller-Huelsbeck S
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):455-67. PubMed ID: 24013534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.